Clinical Trial Update: Liquid Biopsy Assay of EBUS-TBNA Supernatant Fluid for Diagnosing Lung Cancer

View source ↗

Summary

Clinical trial update describing a liquid biopsy assay using EBUS-TBNA supernatant fluid to diagnose lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer
• Pulmonary Nodules

Snippet

Sponsor: Barzilai Medical Center | Conditions: Non Small Cell Lung Cancer, Non Small Cell Lung Cancer (NSCLC) | Status: RECRUITING